AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇸🇳
SOFOSBUVIR/VELPATASVIR in Senegal
5 products registered with ARP — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| EPCLUSA comprimé / 100 mg /400 mg | 9972 | GILEAD SCIENCES | active | — |
| SOVEL comprimé / 400 mg /100 mg | 38574 | SEARLE COMPANY LIMITED | active | — |
| EPCLUSA COMPRIME PELLICULE / 400mg/100mg | UNKNOWN-667ee1bf | GILEAD | active | — |
| EPCLUSA COMPRIME PELLICULE / 400mg/100mg | UNKNOWN-079b113f | GILEAD | active | — |
| EPCLUSA 100 mg /400 mg | 9414 | — | active | — |
SOFOSBUVIR/VELPATASVIR — ARP Registration Details
ARP (Senegal) has 5 registered products containing SOFOSBUVIR/VELPATASVIR, of which 5 are currently active. Data is sourced directly from the official ARP drug register and refreshed daily.
Track SOFOSBUVIR/VELPATASVIR registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.